Pharmacology · Short notes

Biologics and Monoclonal Antibodies: Short Notes & Cheat Sheet

Pharmacology and Therapeutics (IIA) and Pharmaceutical Technology II: recombinant proteins, monoclonal and polyclonal antibodies, their naming and targets, immunosuppressants, interferons, biosimilars and nucleic acid medicines.

Short notes

Read these before you attempt the topic's MCQs.

From mouse to human antibodies

human contentMurine-momab0% humanChimeric-ximabAbout 65% humanHumanised-zumabOver 90% humanHuman-umab100% human
More human sequence means less immunogenicity and fewer infusion reactions.

Making biologics

  • Recombinant DNA technology puts a human gene into bacteria, yeast or mammalian cells; human insulin (1982) was the first recombinant medicine.
  • Monoclonal antibodies come from a single B-cell clone; the hybridoma method was developed by Köhler and Milstein in 1975.
  • Polyclonal antibodies come from many clones in immunised animals or donors: antivenoms, rabies and tetanus immunoglobulins, and intravenous immunoglobulin (IVIG).
  • Biologics are large, made in living cells, given by injection, and can provoke anti-drug antibodies.

Monoclonal antibodies in use

  • Traditional name stems: -ximab chimeric (infliximab, rituximab), -zumab humanised (trastuzumab, omalizumab), -umab fully human (adalimumab).
  • Anti-TNF agents (infliximab, adalimumab; etanercept is a fusion protein) treat rheumatoid arthritis and inflammatory bowel disease. Screen for latent TB and hepatitis B before starting.
  • Other anti-inflammatory targets: IL-6 (tocilizumab), CD20 on B-cells (rituximab), T-cell co-stimulation (abatacept).
  • Asthma: omalizumab binds IgE; mepolizumab blocks IL-5 in eosinophilic asthma.
  • Cancer: trastuzumab (HER2), bevacizumab (VEGF), cetuximab (EGFR), and checkpoint inhibitors nivolumab and pembrolizumab (PD-1) and ipilimumab (CTLA-4).
  • IVIG is used in immunodeficiency, immune thrombocytopenia, Guillain–Barré syndrome and Kawasaki disease.

Immunosuppressants and interferons

  • Calcineurin inhibitors (ciclosporin, tacrolimus) block IL-2 production; both are nephrotoxic and need drug level monitoring.
  • Sirolimus and everolimus inhibit mTOR; azathioprine and mycophenolate block lymphocyte proliferation.
  • Interferon-α was used for hepatitis B and C, interferon-β treats multiple sclerosis, and interferon-γ treats chronic granulomatous disease.

Biosimilars and nucleic acid medicines

  • A biosimilar is highly similar to an approved biologic with no clinically meaningful differences; it is not an identical copy like a small-molecule generic.
  • A biobetter is a deliberately improved version, for example with a longer half-life.
  • mRNA vaccines deliver mRNA in lipid nanoparticles. siRNA drugs (patisiran, 2018) silence genes; antisense oligonucleotides (nusinersen) alter RNA processing.
  • Biologics need cold-chain storage, must not be shaken or frozen, and are tracked by batch for pharmacovigilance.

Cheat sheet

High-yield facts in one place. Cover the right-hand column and test yourself.

Antibody → target → use

AntibodyTarget · use
Infliximab, adalimumabTNF-α · RA, IBD
RituximabCD20 · lymphoma, RA
TocilizumabIL-6 receptor · RA
OmalizumabIgE · allergic asthma
TrastuzumabHER2 · breast cancer
BevacizumabVEGF · colorectal cancer
Nivolumab, pembrolizumabPD-1 · melanoma, lung cancer

Name stem → source

StemSource
-momabMouse
-ximabChimeric
-zumabHumanised
-umabFully human
-ceptReceptor fusion protein

Memory aids

Mouse → miX → humaniZed → hUman
-momab, -ximab, -zumab, -umab: each step contains more human protein and is less immunogenic.

Exam traps

  • Etanercept is a fusion protein ('-cept'), not a monoclonal antibody.
  • Always screen for latent TB before anti-TNF therapy.
  • A biosimilar is not a generic; small manufacturing differences are expected.
  • Calcineurin inhibitors are nephrotoxic, so their levels are monitored.

Revised? Now test yourself.

Attempt the Biologics and Monoclonal Antibodies MCQs while the notes are fresh. Anything you get wrong is saved to your incorrect list for the next revision round.

More Pharmacology notes